A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Paul M. Ridker, Douglas E. Vaughan, JE Manson et al. · The Lancet · 1993 · 583 citations

Thrombosis, Heart Failure, Cardiovascular Disease +6

Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis

I. Juhan‐Vague, J Valadier, Marie‐Christine Alessi et al. · Thrombosis and Haemostasis · 1987 · 367 citations

Relationships between Euglobulin Clot Lysis Time and the Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1

Tetsumei Urano, Kenji Sakakibara, Andrzej Rydzewski et al. · Thrombosis and Haemostasis · 1990 · 119 citations

Inhibitory Activity, Plasma Levels, Clot Lysis Time +14

Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.

Jeffrey I. Weitz, Beverly A. Leslie, Jeffrey S. Ginsberg · Journal of Clinical Investigation · 1991 · 73 citations · Full text

Engineering, Immunology, Biomedical Engineering +18

Native Fibrin Gel Networks and Factors Influencing their Formation in Health and Disease

Birger Blombäck, D. Banerjee, Kjell Carlsson et al. · Advances in experimental medicine and biology · 1990 · 47 citations

Tissue Engineering, Fibrosis, Engineering +10